![Matthew Hawryluk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Hawryluk
Direktor/Vorstandsmitglied bei
PRECISION THERAPEUTICS INC
Vermögen: 81 737 $ am 31.05.2026
Profil
Matthew J.
Hawryluk is currently Independent Director at Axe Compute, Inc. since 2022, Director at Ourotech, Inc., and Chief Business Officer at Prime Medicine, Inc. starting in 2025.
Formerly, Dr. Hawryluk was Vice President-Corporate & Business Development at Foundation Medicine, Inc. and Chief Business Officer & Executive Vice President at Gritstone bio, Inc. from 2015 to 2024.
Education includes undergraduate studies at the University of Notre Dame, an MBA from Tepper School of Business, and a doctorate from the University of Pittsburgh School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AXE COMPUTE INC. 0,35 % | 20.04.2026 | 11 727 ( 0,35 % ) | 81 737 $ | 31.05.2026 |
Aktive Positionen von Matthew Hawryluk
| Unternehmen | Position | Beginn |
|---|---|---|
| PRECISION THERAPEUTICS INC | Direktor/Vorstandsmitglied | 29.11.2022 |
| PRIME MEDICINE, INC. | Corporate Officer/Principal | 03.11.2025 |
Ourotech, Inc.
 Ourotech, Inc. Medical SpecialtiesHealth Technology Manufactures cancer treatment devices | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Matthew Hawryluk
| Unternehmen | Position | Ende |
|---|---|---|
| GRITSTONE BIO, INC. | Corporate Officer/Principal | 31.12.2024 |
| FOUNDATION MEDICINE INC | Corporate Officer/Principal | - |
Ausbildung von Matthew Hawryluk
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
10
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Predictive Oncology, Inc.
 Predictive Oncology, Inc. Medical SpecialtiesHealth Technology Operates as a development stage company manufacturing an environmentally conscientious system for the collection and disposal of infectious fluids | Health Technology |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
Tepper School of Business
 Tepper School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pittsburgh School of Medicine
 University of Pittsburgh School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gritstone bio, Inc.
 Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
Ourotech, Inc.
Ourotech, Inc. Medical SpecialtiesHealth Technology Manufactures cancer treatment devices | Health Technology |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
